|
DCBLD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.010860E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.594800E-04 |
| Normal-vs-Stage2 |
1.950830E-01 |
| Normal-vs-Stage3 |
7.596700E-03 |
| Normal-vs-Stage4 |
9.503500E-03 |
| Stage1-vs-Stage2 |
1.519150E-01 |
| Stage1-vs-Stage3 |
8.263600E-01 |
| Stage1-vs-Stage4 |
2.552200E-01 |
| Stage2-vs-Stage3 |
3.575600E-01 |
| Stage2-vs-Stage4 |
8.692300E-02 |
| Stage3-vs-Stage4 |
2.423800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.436800E-04 |
| Normal-vs-AfricanAmerican |
1.358040E-02 |
| Normal-vs-Asian |
1.287640E-01 |
| Caucasian-vs-AfricanAmerican |
5.718600E-01 |
| Caucasian-vs-Asian |
2.079200E-01 |
| AfricanAmerican-vs-Asian |
2.382800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.884000E-03 |
| Normal-vs-Female |
2.53220000001608E-06 |
| Male-vs-Female |
3.488100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.662100E-02 |
| Normal-vs-Age(41-60Yrs) |
4.032500E-04 |
| Normal-vs-Age(61-80Yrs) |
1.542410E-03 |
| Normal-vs-Age(81-100Yrs) |
1.588180E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.141800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.624800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.902000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.907000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.625200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.415200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.144720E-03 |
| Normal-vs-Grade 2 |
3.87020000000016E-05 |
| Normal-vs-Grade 3 |
9.176100E-02 |
| Normal-vs-Grade 4 |
2.776700E-03 |
| Grade 1-vs-Grade 2 |
2.664600E-01 |
| Grade 1-vs-Grade 3 |
1.630360E-02 |
| Grade 1-vs-Grade 4 |
5.737200E-01 |
| Grade 2-vs-Grade 3 |
1.384830E-03 |
| Grade 2-vs-Grade 4 |
1.116620E-01 |
| Grade 3-vs-Grade 4 |
1.358120E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.783220E-04 |
| Normal-vs-ccB subtype |
3.781700E-03 |
| ccA subtype-vs-ccB subtype |
7.084000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.214500E-04 |
| Normal-vs-N1 |
6.488000E-01 |
| N0-vs-N1 |
3.318200E-01 |
|
|
